Rani Therapeutics Inc.
RANI | NASDAQ
$0.79
$0 (+0.08%)
Sep 22, 2026, 2:46 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.71M | 1.71M | 1.46M | n/a | n/a | 172K | 1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.96M | 756K |
Cost of Revenue | n/a | 161K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.71M | 1.55M | 1.46M | n/a | n/a | 172K | 1.03M | n/a | n/a | -248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.96M | 756K |
Operating Income | -8.83M | -8.34M | -8.54M | -7.26M | -10.51M | -12.01M | -14.96M | -11.8M | -12.52M | -14.03M | -13.43M | -17.86M | -18.29M | -16.52M | -17.48M | -16.34M | -15.85M | -13.78M | -13.36M | -27.78M | -5.26M | -5.2M |
Interest Income | 415K | 412K | 384K | 68K | 158K | 218K | 360K | 414K | 439K | 549K | 675K | 839K | 896K | 891K | 818K | 379K | 35K | 15K | 16K | 13K | 13K | 47K |
Pretax Income | -8.42M | -8.02M | -9.07M | -7.91M | -11.22M | -12.74M | -15.72M | -12.72M | -13.36M | -14.78M | -14.06M | -18.33M | -18.66M | -16.83M | -17.38M | -16.32M | -15.81M | -13.77M | -13.35M | -28.66M | -5.48M | -5.56M |
Net Income | -7.39M | -7.03M | -10.31M | -5.41M | -6.69M | -7.26M | -8.95M | -6.78M | -6.81M | -7.48M | -7.1M | -9.2M | -9.3M | -8.37M | -8.79M | -7.96M | -7.62M | -6.22M | -5.19M | -3.14M | -5.49M | -5.6M |
Selling & General & Admin | 5.52M | 4.89M | 5.09M | 4.04M | 5M | 5.62M | 5.46M | 5.63M | 6.41M | 6.2M | 5.83M | 6.64M | 7.21M | 6.8M | 7.1M | 7.24M | 6.32M | 6.19M | 5.95M | 15.82M | 3.46M | 2.61M |
Research & Development | 5.02M | 5.16M | 4.91M | 3.22M | 5.51M | 6.57M | 6.81M | 6.17M | 6.12M | 7.59M | 7.61M | 11.22M | 11.09M | 9.71M | 10.39M | 9.1M | 9.53M | 7.59M | 7.42M | 11.96M | 3.76M | 3.35M |
Other Expenses | n/a | -161K | n/a | n/a | n/a | n/a | 3.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.54M | 9.89M | 10M | 7.26M | 10.51M | 12.19M | 15.99M | 11.8M | 12.52M | 13.79M | 13.43M | 17.86M | 18.29M | 16.52M | 17.48M | 16.34M | 15.85M | 13.78M | 13.36M | 27.78M | 7.22M | 5.95M |
Interest Expense | 8K | 88K | 347K | 725K | 877K | 943K | 1.12M | 1.34M | 1.28M | 1.29M | 1.3M | 1.32M | 1.27M | 1.21M | 719K | 352K | n/a | n/a | n/a | 110K | 169K | 188K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.54M | 10.05M | 10M | 7.26M | 10.51M | 12.19M | 15.99M | 11.8M | 12.52M | 14.03M | 13.43M | 17.86M | 18.29M | 16.52M | 17.48M | 16.34M | 15.85M | 13.78M | 13.36M | 27.78M | 7.22M | 5.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -41K | -107K | 154K | 63K | -40K | 37K | 1K | 43K |
Shares Outstanding (Basic) | 187.17M | 180M | 147.09M | 36.54M | 36.54M | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M | 25.87M | 25.55M | 25.35M | 25.24M | 24.91M | 24.47M | 24.37M | 21.41M | 19.44M | 19.44M | 18.81M | 18.74M |
Shares Outstanding (Diluted) | 187.17M | 180M | 147.09M | 36.54M | 36.54M | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M | 25.87M | 25.55M | 25.35M | 25.24M | 24.91M | 24.47M | 24.37M | 21.41M | 19.44M | 19.44M | 18.81M | 18.74M |
EPS (Basic) | -0.04 | -0.04 | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 | -0.27 | -0.36 | -0.37 | -0.33 | -0.35 | -0.33 | -0.31 | -0.29 | -0.26 | -0.16 | -0.29 | -0.30 |
EPS (Diluted) | -0.04 | -0.04 | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 | -0.27 | -0.36 | -0.37 | -0.33 | -0.35 | -0.33 | -0.31 | -0.29 | -0.26 | -0.16 | -0.29 | -0.30 |
EBITDA | -8.83M | -7.77M | -8.54M | -6.97M | -10.11M | -11.54M | -14.33M | -11.13M | -11.83M | -13.24M | -12.53M | -16.8M | -17.21M | -15.44M | -16.49M | -15.82M | -15.69M | -13.65M | -13.23M | -28.43M | -5.19M | -5.23M |
EBIT | -8.83M | -7.93M | -8.73M | -7.19M | -10.35M | -11.8M | -14.6M | -11.39M | -12.09M | -13.49M | -12.76M | -17.02M | -17.4M | -15.63M | -16.66M | -15.96M | -15.81M | -13.77M | -13.35M | -28.55M | -5.32M | -5.37M |
Depreciation & Amortization | n/a | 161K | 186K | 223K | 240K | 251K | 266K | 259K | 255K | 248K | 227K | 218K | 189K | 188K | 174K | 141K | 122K | 111K | 113K | 120K | 128K | 136K |
Add to Watchlist
Select watchlists to add or remove RANI